Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ray

Showing results (161-170 of 229) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 14, 2009
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failureS George, J Y Blay, P G Casali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)K Fujiwara, B J Monk, C Lhommé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trialA Le Cesne, J Y Blay, I Judson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 27, 2020
Clinical management of adolescents and young adults suffering from sarcoma in the French Rhône-Alpes region: A prospective exhaustive cohort with 10 years follow upP Marec-Bérard, S Aho, C Berger, et al.
ESMO Open|March 7, 2022
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trialsE F Nassif, J-Y Blay, C Massard, et al.
British Journal of Cancer|August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma GroupP A Cassier, A Lefranc, E Y Amela, et al.
British Journal of Cancer|May 30, 2018
Author Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2017
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network settingI Ray-Coquard, AnnaLisa Trama, M J Seckl, et al.
British Journal of Cancer|June 28, 2017
Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2009
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanesS Pecorelli, I Ray-Coquard, O Tredan, et al.
Pageof 23

Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|March 14, 2009
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failureS George, J Y Blay, P G Casali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)K Fujiwara, B J Monk, C Lhommé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trialA Le Cesne, J Y Blay, I Judson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 27, 2020
Clinical management of adolescents and young adults suffering from sarcoma in the French Rhône-Alpes region: A prospective exhaustive cohort with 10 years follow upP Marec-Bérard, S Aho, C Berger, et al.
ESMO Open|March 7, 2022
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trialsE F Nassif, J-Y Blay, C Massard, et al.
British Journal of Cancer|August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma GroupP A Cassier, A Lefranc, E Y Amela, et al.
British Journal of Cancer|May 30, 2018
Author Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2017
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network settingI Ray-Coquard, AnnaLisa Trama, M J Seckl, et al.
British Journal of Cancer|June 28, 2017
Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2009
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanesS Pecorelli, I Ray-Coquard, O Tredan, et al.
Pageof 23